INSIGHTS ON DRUG DEVELOPMENT
-
Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis
Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
API In Capsule Vs. The Lost Art Of Formulation Development
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
How Do You Start Process Transfer For A New Client?
Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.
-
The Top Tech Transfer Risks At Multi-Site CDMOs3/31/2026
Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.
-
Benchmarking Filtration Performance Of TFF Cassettes5/30/2025
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Lentiviral Vector Upstream Process12/12/2025
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Five Practical Considerations To Move From Concept To Clinic12/17/2025
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
-
Rapid Automated Selection Of Mammalian Cell Colonies3/17/2025
Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.
DRUG DEVELOPMENT SOLUTIONS
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Uniquely Ergonomic System Microscopes With Intelligent Automation Leica DM3000 LED
Enhance Laboratory Workflow
The Leica DM3000 LED microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
A60 F Stereo Microscope
Optimize your productivity and production quality
The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
-
See 80% more of your sample with a 46 mm object field
-
Comfortable access your sample due to the 122 mm working distance
-
Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
-
Enables large surface overview and detailed observation with a magnification range from 5x to 30x
-
-
Custom microscopy workstations to meet your advanced imaging needs.
-
Integrate an automated cell imaging system with high-resolution imaging and robust analytics into your processes to streamline workflows for fluorescence and brightfield assays.